[ANNONCE] Next French Healthcare: developing the group's expertise internationally
We are proud to announce that Neolys Diagnostics has been selected to be part of the the #NEXTFrenchHealthcare program, Business France North America!
Dedicated to innovative startups in the Digital Health and Medtechthis program will address the key points of access to the North American market.
Thanks to its strong network, French Healthcare offers French healthcare companies visibility and opportunities on the international stage to support their export growth.
An opportunity for the group to present its expertise, its commitments and its successes
- PROMOTE French expertise in health at the international level and highlight the individual members of the association.
- FEDERATE French healthcare companies, in order to develop collective offers to meet foreign needs.
- ATTRACT, contribute to the attractiveness of France.
Congratulations to all the winners! Our teams are looking forward to participating in the masterclasses and meeting the experts.
We thank the program organizers, the members of the Jury and PariSanté Campus for their support of health innovations!
Neolys Diagnostics is helping to improve therapeutic efficacy in the face of cancer.
Limiting the side effects of radiotherapy treatment with our predictive radiosensitivity tests is possible!
For any information about our tests, contact us âž” https://lnkd.in/e_e-RMN